SCHEMBL24649618

SCHEMBL24649618

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc4cc(-c5ccccc5)ccc4c1)c1c2oc2ccccc21)C(C)(C)c1cc(-c2ccc4cc(-c5ccccc5)ccc4c2)c2c(oc4ccccc42)c1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 2/20 0.36
▸ PLA2G2A P14555 2/20 0.33
▸ PLA2G4A P47712 2/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ CDC14B O60729 2/20 0.32
▸ CDC14A Q9UNH5 2/20 0.32
▸ LPL P06858 1/20 0.32
▸ LIPG Q9Y5X9 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ MAPT P10636 3/20 0.31
▸ ALK Q9UM73 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ CSNK2A2 P19784 1/20 0.31
▸ CSNK2B P67870 1/20 0.31
▸ PIM3 Q86V86 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205524 0.93 GPR84 (0.35) PGRALOX5LPLLIPGGPR84
SCHEMBL20205642 0.92 PGR (0.37) PGRPLA2G2APLA2G4AALOX5CDC14B
SCHEMBL20205309 0.92 PLA2G2A (0.36) PGRPLA2G2APLA2G4AALOX5CDC14B
SCHEMBL20205313 0.92 CDC14B (0.38) PGRPLA2G2APLA2G4AALOX5CDC14B
SCHEMBL24649889 0.91 GPR84 (0.35) PGRALOX5LPLLIPGGPR84
SCHEMBL20205307 0.89 CDC14B (0.39) PGRCDC14BCDC14AMAPTALK
SCHEMBL24649753 0.89 PLA2G2A (0.35) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205323 0.89 PLA2G2A (0.34) PGRPLA2G2APLA2G4AALOX5CDC14B
SCHEMBL20205741 0.88 CDC14B (0.36) PGRPLA2G2APLA2G4AALOX5CDC14B
SCHEMBL20205319 0.88 CDC14B (0.34) PGRPLA2G2APLA2G4AALOX5CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PGR 4271/4885PLA2G2A 1854/4885PLA2G4A 2777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback